Visus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Visus Therapeutics's estimated annual revenue is currently $4.6M per year.
- Visus Therapeutics's estimated revenue per employee is $77,500
- Visus Therapeutics's total funding is $56M.
Employee Data
- Visus Therapeutics has 59 Employees.
- Visus Therapeutics grew their employee count by 13% last year.
Visus Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, Executive Director | Reveal Email/Phone |
2 | VP, Human Resources | Reveal Email/Phone |
3 | VP Marketing | Reveal Email/Phone |
4 | VP Pharmaceutical Development | Reveal Email/Phone |
5 | VP Clinical & Medical Affairs | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Director Clinical Operations | Reveal Email/Phone |
8 | Executive Director, Clinical Operations | Reveal Email/Phone |
9 | Director | Reveal Email/Phone |
10 | Executive Assistant / Office Manager | Reveal Email/Phone |
Visus Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $3.3M | 43 | 10% | $101M | N/A |
#4 | $5.7M | 37 | 12% | N/A | N/A |
#5 | $7M | 45 | 41% | N/A | N/A |
#6 | $1.7M | 22 | -8% | N/A | N/A |
#7 | $3.9M | 50 | 4% | $10.1M | N/A |
#8 | $1.9M | 12 | -73% | N/A | N/A |
#9 | $29.3M | 151 | -17% | $148M | N/A |
#10 | $2M | 13 | 86% | N/A | N/A |
What Is Visus Therapeutics?
Visus Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world. With offices in Seattle, WA and Irvine, CA., our lead clinical candidate is BRIMOCHOL, an investigational drug designed to be a once-daily eye drop to correct for the loss of near vision associated with presbyopia. In parallel, Visus Therapeutics is focused on advancing its pipeline of early-stage ophthalmic product candidates with applications in ocular surface disease, glaucoma, and age-related macular degeneration.
keywords:N/A
$56M
Total Funding
59
Number of Employees
$4.6M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Visus Therapeutics News
Visus Therapeutics launched the first of two pivotal Phase III Trials for Brimochol PF for presbyopia. Presbyopia is loss of near vision...
Visus Therapeutics kicks off Phase 3 pivotal trial for presbyopia treatment ... The company has dosed the first patients in a Phase 3 trial...
With offices in Seattle, Wash., and Irvine, Calif., Visus Therapeutics is a clinical-stage pharmaceutical company focused on developing...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.4M | 59 | 2% | N/A |
#2 | $7.7M | 59 | 2% | N/A |
#3 | $16.4M | 59 | 20% | N/A |
#4 | $17M | 59 | 168% | N/A |
#5 | $9.6M | 59 | -8% | N/A |